Why the order matters
The right sequence isn't a preference, it's the difference between a program that compounds and one that burns cash. The order is: foundation, then conversion path, then fuel. Foundation means prescriber coverage, pharmacy fulfillment, and intake/payment flows working end-to-end. Conversion path means booking, checkout, and the patient portal tested — so every click has somewhere to land. Only then do you switch on growth, with tracking and full ad-spend transparency.
Prescriber
Medical director / prescriber coverage for the states you serve.
Pharmacy
503A and/or 503B fulfillment wired to your consults.
Platform
Intake, checkout, and portal tested end-to-end.
Patients
Growth switched on only when the machine underneath is ready.
Step one: prescriber coverage
In most states you can't prescribe GLP-1 therapy without a medical director or appropriate prescriber coverage for the jurisdictions your patients are in. This is the first domino — no coverage, no program. A doctor's network can provide directorship and on-demand licensed consults across all 50 states through one relationship, and the key term to protect is ownership: structure it so your patients, records, and data belong to your practice. Our guide to getting a medical director in all 50 states covers the ownership trap in detail, and the doctor's network page shows how coverage works.
Step two: the compounded GLP-1 reality
That language is the compliance floor, and it shapes what your practice can honestly say in its marketing and to patients. Never describe a compounded GLP-1 product as FDA-approved or as equivalent to an approved brand-name drug. Where a program uses compounded therapy, that fact belongs on the page, on the consent, and in the conversation.
On fulfillment: most practices use both pharmacy types — 503A for patient-specific prescriptions shipped direct to telehealth patients, and 503B for standardized office stock. If that distinction is new, read the 503A vs 503B guide, then set up access through a pharmacy network so you're comparing verified options instead of depending on a single relationship.
Step three: what the clinic needs in place
Before a single patient enters the funnel, these three have to work together:
- Medical director / prescriber coverage for every state you serve — the legal foundation of the program.
- 503A/503B pharmacy access so consults turn into fulfilled prescriptions, direct-to-patient or as office stock.
- Intake and EHR flow — booking, consult routing, checkout, and a patient portal, tested end-to-end so nothing bottlenecks between intake and fulfillment.
A branded EHR ties intake to consult to fulfillment; the supplies marketplace covers the syringes and administration materials patients and staff need. Get these connected before you spend a dollar on ads.
The six-week program model (and a non-injectable option)
Not every weight patient is a candidate for — or wants — injectable therapy, and building a second lane keeps price-sensitive patients inside your practice. A six-week, provider-supervised app-guided program pairs an all-natural regimen with a structured nutrition plan and a patient app — tracking, education, and provider chat included — followed by a maintenance phase that keeps patients engaged with your practice. The app handles tracking and education, which reduces staff time per patient, and the built-in maintenance phase creates recurring revenue after week six.
It fits patients transitioning off injectable weight-loss therapy, patients who aren't candidates for it, and price-sensitive patients you'd otherwise lose. Run it as a complement to a GLP-1 line, not a replacement — the two serve different patients. See how the packaged program is structured on the programs page.
Economics — framed honestly
A GLP-1 line and a companion program add revenue lines with different cost structures: the injectable line carries prescriber and pharmacy economics, the app-guided program runs with no capital equipment and a maintenance phase that recurs. Beyond that, the honest answer is that results and returns vary by practice and by patient, and no income or outcome is guaranteed. Model your own numbers — patient volume, program pricing, fulfillment costs — the same disciplined way you'd model a device purchase. What this guide can promise is the sequence; the economics are yours to build.